Impact of relacorilant, a selective glucocorticoid receptor antagonist, on the immunosuppressive effects of endogenous cortisol.
Greenstein et al. • 2020 • Citation: J Clin Oncol 38: 2020 (suppl; abstract #: 3091)
Greenstein et al. • 2020 • Citation: J Clin Oncol 38: 2020 (suppl; abstract #: 3091)
Munster et al. • 2019 •
Kach et al. • 2017 • Mol Cancer Ther. 2017;16(8):1680-1692.
Block et al. • 2017 • Cancer Manag Res. 2017;9:65-72.
Skor et al. • 2013 • Clin Cancer Res. 2013;19(22):6163-72.
Isikbay et al. • 2014 • Horm Cancer. 2014;5(2):72-89.
Stringer-Reasor et al. • 2015 • Gynecol Oncol. 2015;138(3):656-62.
Isaacs JT • 1999 • Urol Clin North Am. 1999;26(2):263-73.
Conzen SD • 2008 • Mol Endocrinol.2008;22(10):2215-28.
Nanda R. • 2011 • Semin Oncol. 2011;38(2):254-62.